Second Affiliated Hospital of Chengdu University of Traditional Chinese
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review synthesizing preclinical concepts, mechanistic insights, and early translational work on engineered bacteria for cancer therapy; it raises questions and explores possibilities rather than reporting a primary clinical trial result or definitive evidence.
Systematic comparison of three rat models against clinical PMOS features, but uncontrolled animal work with small per-group samples (n=8) and no between-model statistical testing reported; provides descriptive phenotypic characterization to guide model selection rather than a testable clinical or mechanistic finding.